Invexans Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Invexans.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Electrical earnings growth	22.5%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Invexans (SNSE:INVEXANS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 01

Returns On Capital Are Showing Encouraging Signs At Invexans (SNSE:INVEXANS)

Mar 30

Introducing Invexans (SNSE:INVEXANS), The Stock That Zoomed 155% In The Last Year

Feb 16

Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?

Dec 23

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Invexans has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:INVEXANS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2023	5,652	243	-1	145	N/A
3/31/2023	5,451	158	-60	86	N/A
12/31/2022	5,125	168	-68	79	N/A
9/30/2022	4,821	183	-63	64	N/A
6/30/2022	4,544	179	-41	80	N/A
3/31/2022	4,172	141	40	146	N/A
12/31/2021	3,804	135	115	191	N/A
9/30/2021	3,401	148	159	229	N/A
6/30/2021	2,967	123	210	274	N/A
3/31/2021	2,627	37	118	172	N/A
12/31/2020	1,833	16	94	141	N/A
9/30/2020	1,132	-47	48	77	N/A
6/30/2020	539	-42	-25	-13	N/A
3/31/2020	0	-46	0	0	N/A
12/31/2019	0	-46	0	0	N/A
9/30/2019	0	-55	0	0	N/A
6/30/2019	0	-57	-3	-3	N/A
3/31/2019	0	-14	1	1	N/A
12/31/2018	0	-13	2	2	N/A
9/30/2018	N/A	9	2	2	N/A
6/30/2018	N/A	10	5	5	N/A
3/31/2018	N/A	34	2	2	N/A
12/31/2017	0	36	2	2	N/A
9/30/2017	0	33	2	2	N/A
6/30/2017	0	35	2	2	N/A
3/31/2017	0	16	N/A	-4	N/A
12/31/2016	0	13	N/A	-3	N/A
9/30/2016	0	-28	N/A	-3	N/A
6/30/2016	0	-29	N/A	-4	N/A
3/31/2016	0	-59	N/A	-4	N/A
12/31/2015	0	-64	N/A	-4	N/A
9/30/2015	0	-95	N/A	-6	N/A
6/30/2015	0	-104	N/A	-6	N/A
3/31/2015	1	-78	N/A	-7	N/A
12/31/2014	1	-74	N/A	-7	N/A
9/30/2014	1	-62	N/A	-9	N/A
6/30/2014	1	-53	N/A	-8	N/A
3/31/2014	1	-93	N/A	-3	N/A
12/31/2013	1	-93	N/A	1	N/A
9/30/2013	1	-28	N/A	4	N/A
6/30/2013	0	-33	N/A	9	N/A
3/31/2013	0	10	N/A	8	N/A
12/31/2012	0	44	N/A	12	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if INVEXANS's forecast earnings growth is above the savings rate (4.5%).

Earnings vs Market: Insufficient data to determine if INVEXANS's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if INVEXANS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if INVEXANS's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if INVEXANS's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if INVEXANS's Return on Equity is forecast to be high in 3 years time

Invexans Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Invexans (SNSE:INVEXANS) Is Looking To Continue Growing Its Returns On Capital

Investor sentiment deteriorates as stock falls 18%

Second quarter 2023 earnings released: EPS: US$0.004 (vs US$0.002 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0 (vs US$0.001 in 1Q 2022)

Investor sentiment improves as stock rises 20%

The Return Trends At Invexans (SNSE:INVEXANS) Look Promising

Investor sentiment improves as stock rises 28%

Full year 2022 earnings released: EPS: US$0.003 (vs US$0.003 in FY 2021)

No independent directors

Invexans (SNSE:INVEXANS) Is Doing The Right Things To Multiply Its Share Price

Second quarter 2022 earnings released: EPS: US$0.002 (vs US$0.001 in 2Q 2021)

First quarter 2022 earnings released: EPS: US$0.001 (vs US$0 in 1Q 2021)

No independent directors

Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly

Second quarter 2021 earnings released: EPS US$0.001 (vs US$0.001 loss in 2Q 2020)

We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt